You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Refocusing the Image: Diagnostic Imaging Within Prostate Cancer

  • Authors: Paul L. Nguyen, MD; Gerald L. Andriole, MD; Andrei H. Iagaru, MD
  • CME Released: 2/3/2022
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 2/3/2023
Start Activity


Target Audience and Goal Statement

This activity is intended for radiation oncologists, nuclear medicine specialists, urologists, and oncologists.

The goal of this activity is to educate clinicians about the diagnostic imaging approaches available in prostate cancer and prime them to integrate these testing modalities into their clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinically available positron emission tomography (PET) tracers used for imaging prostate cancer
    • Efficacy data associated with PET tracers used for imaging prostate cancer
  • Have greater competence related to
    • Selecting the most appropriate patients for PET imaging
  • Demonstrate greater confidence in their ability to
    • Select the appropriate PET imaging approach in patients with prostate cancer


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Paul L. Nguyen, MD

    Genitourinary Clinical Center Director for Radiation Oncology
    Senior Physician
    Professor of Radiation Oncology, Harvard Medical School
    Dana Farber Cancer Center
    Boston, Massachusetts

    Disclosures

    Advisor or consultant for: Astellas; Boston Scientific; Cota; Janssen; Myovant
    Research funding from: Astellas; Bayer; Janssen
    Stocks, stock options, or bonds from: Synedgen

  • Gerald L. Andriole, MD

    Professor and Director
    Brady Urologic Institute
    National Capital Region
    Johns Hopkins University
     

    Participation by Dr Andriole does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

    Disclosures

    Grants for clinical research from: Blue Earth Diagnostics; Ferring; Nanospectra
    Advisor or consultant for: Exact Imaging; Opko; Stratify Genomics
    Stocks, stock options, or bonds from: Stratify Genomics; OPKO

  • Andrei H. Iagaru, MD

    Professor of Radiology and Nuclear Medicine
    Chief, Division of Nuclear Medicine and Molecular Imaging
    Stanford Health Care
    Stanford, California

    Disclosures

    Advisor or consultant for: Clarity; GE Healthcare; ITM; Lantheus; Novartis
    Research funding from: GE Healthcare; ITM; Lantheus

Editor

  • Davecia Ragoonath Cameron, MS

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Davecia Ragoonath Cameron, MS, has disclosed no relevant financial relationships.

  • Jason Luis Quiñones, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Jason Luis Quiñones , PhD, has disclosed no relevant financial relationships.

  • Christin Melton, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Christin Melton, ELS, has disclosed no relevant financial relationships.

Compliance Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Refocusing the Image: Diagnostic Imaging Within Prostate Cancer

Authors: Paul L. Nguyen, MD; Gerald L. Andriole, MD; Andrei H. Iagaru, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 2/3/2022

Valid for credit through: 2/3/2023

processing....

Educational Impact Challenge

The goal of this activity is to educate clinicians about the diagnostic imaging approaches available in prostate cancer and prime them to integrate these testing modalities into their clinical practice.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print